Ahmed Muhammad, Alim Ur Rahman Hafsah, Fahim Muhammad Ahmed Ali, Hussain Zahabia Altaf, Ahmed Nisar, Asghar Muhammad Sohaib
Shaheed Mohtarma Benazir Bhutto Medical College, Lyari, Karachi, Pakistan.
Dow Medical College, Dow University of Health Sciences, Karachi, Pakistan.
Front Cardiovasc Med. 2024 Aug 26;11:1438556. doi: 10.3389/fcvm.2024.1438556. eCollection 2024.
Patients with prior cardiac surgery undergoing acute type A aortic dissection (ATAAD) are thought to have worse clinical outcomes as compared to the patients without prior cardiac surgery.
To compare the safety and efficacy of ATAAD in patients with prior cardiac surgery.
We systematically searched PubMed, Cochrane Library and Google Scholar from database inception until April 2024. We included nine studies which consisted of a population of 524 in the prior surgery group and 5,249 in the non-prior surgery group. Our primary outcome was mortality. Secondary outcomes included reoperation for bleeding, myocardial infarction, stroke, renal failure, sternal wound infection, cardiopulmonary bypass (CPB) time, cross-clamp time, hospital stay, and ICU stay.
Our pooled estimate shows a significantly lower rate of mortality in the non-prior cardiac surgery group compared to the prior cardiac surgery group (RR = 0.60, 95% CI = 0.48-0.74). Among the secondary outcomes, the rate of reoperation for bleeding was significantly lower in the non-prior cardiac surgery group (RR = 0.66, 95% CI = 0.50-0.88). Additionally, the non-prior cardiac surgery group had significantly shorter CPB time (MD = -31.06, 95% CI = -52.20 to -9.93) and cross-clamp time (MD = -21.95, 95% CI = -42.65 to -1.24). All other secondary outcomes were statistically insignificant.
Patients with prior cardiac surgery have a higher mortality rate as compared to patients who have not undergone cardiac surgery previously. Patients with prior cardiac surgery have higher mortality and longer CPB and cross-clamp times. Tailored strategies are needed to improve outcomes in this high-risk group.
与未接受过心脏手术的患者相比,曾接受心脏手术的患者发生急性A型主动脉夹层(ATAAD)时,临床结局被认为更差。
比较曾接受心脏手术的患者中ATAAD治疗的安全性和有效性。
我们系统检索了从数据库建立至2024年4月的PubMed、Cochrane图书馆和谷歌学术。我们纳入了9项研究,其中既往手术组有524例患者,非既往手术组有5249例患者。我们的主要结局是死亡率。次要结局包括因出血、心肌梗死、中风、肾衰竭、胸骨伤口感染而再次手术、体外循环(CPB)时间、主动脉阻断时间、住院时间和重症监护病房(ICU)停留时间。
我们的汇总估计显示,与既往心脏手术组相比,非既往心脏手术组的死亡率显著更低(RR = 0.60,95%CI = 0.48 - 0.74)。在次要结局中,非既往心脏手术组因出血而再次手术的发生率显著更低(RR = 0.66,95%CI = 0.50 - 0.88)。此外,非既往心脏手术组的CPB时间显著更短(MD = -31.06,95%CI = -52.20至-9.93),主动脉阻断时间也显著更短(MD = -21.95,95%CI = -42.65至-1.24)。所有其他次要结局在统计学上均无显著差异。
与既往未接受过心脏手术的患者相比,曾接受心脏手术的患者死亡率更高。曾接受心脏手术的患者死亡率更高,CPB时间和主动脉阻断时间更长。需要制定针对性策略以改善这一高危人群的结局。